E-LIB Suche - Ergebnisse für: Hoimes, C.J.

1

8P Factors associated with primary progression in patients ..:

Jindal, T. ; Jiang, C. ; Alhalabi, O....
ESMO Open. 9 (2024) - p. 102263 , 2024

Link: https://doi.org/10.1016/..

2

PCR53 Patient Experiences Before and After Enfortumab Vedot..:

Flaig, T ; Hepp, Z ; Narayanan, S...
Value in Health. 25 (2022) 12 - p. S400 , 2022

Link: https://doi.org/10.1016/..

3

KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus en..:

McDermott, R. ; Graff, J.N. ; Antonarakis, E.S....
European Urology Open Science. 19 (2020) - p. e885-e886 , 2020

Link: https://doi.org/10.1016/..

4

EV-103 Study: A phase 1b dose-escalation and dose-expansion..:

Hoimes, C.J. ; Petrylak, D. ; Flaig, T....
European Urology Supplements. 17 (2018) 2 - p. e1151 , 2018

Link: https://doi.org/10.1016/..

5

Phase II California Cancer Consortium trial of gemcitabine–..:

Sadeghi, S. ; Groshen, S. ; Parikh, R....
European Journal of Cancer. 72 (2017) - p. S197 , 2017

Link: https://doi.org/10.1016/..

6

Outcomes of Antineoplastic Immunotherapy at a Large Healthc..:

Mirsky MM ; Mitchell C ; Hong A...
https://www.dovepress.com/outcomes-of-antineoplastic-immunotherapy-at-a-large-healthcare-organiz-peer-reviewed-fulltext-article-CMAR. , 2023

Link: https://doaj.org/article..

7

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib..:

Beltran H ; Oromendia C ; Danila D. C...
info:eu-repo/semantics/altIdentifier/pmid/30232224. , 2019

Link: http://hdl.handle.net/11..

8

KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus en..:

R. McDermott ; J.N. Graff ; E.S. Antonarakis...
http://www.sciencedirect.com/science/article/pii/S2666168320331712. , 2020

Link: https://doi.org/10.1016/..

9

Assessing the utility of molecular diagnostic classificatio..:

Moore, Elle C. ; Blobe, Gerard C. ; DeVito, Nicholas C....
Cancer Medicine. 12 (2023) 19 - p. 19394-19405 , 2023

Link: https://doi.org/10.1002/..

10

Society for Immunotherapy of Cancer (SITC) clinical practic..:

Galsky, Matthew D ; Balar, Arjun V ; Black, Peter C...
Journal for ImmunoTherapy of Cancer. 9 (2021) 7 - p. e002552 , 2021

Link: https://doi.org/10.1136/..

11

Efficacy of enfortumab vedotin in advanced urothelial cance..:

Koshkin, Vadim S. ; Henderson, Nicholas ; James, Marihella...
Cancer. 128 (2021) 6 - p. 1194-1205 , 2021

Link: https://doi.org/10.1002/..

12

Imaging and clinical manifestations of immune checkpoint in..:

Shieh, Alice C. ; Guler, Ezgi ; Pfau, David...
Abdominal Radiology. 45 (2019) 10 - p. 3028-3035 , 2019

Link: https://doi.org/10.1007/..

13

A phase 1 trial of SGN‐CD70A in patients with CD70‐positive..:

Pal, Sumanta K. ; Forero‐Torres, Andres ; Thompson, John A....
Cancer. 125 (2019) 7 - p. 1124-1132 , 2019

Link: https://doi.org/10.1002/..

14

Myeloid-derived suppressors cells (MDSC) correlate with cli..:

Ornstein, Moshe C. ; Diaz-Montero, Claudia Marcela ; Rayman, Patricia...
Urologic Oncology: Seminars and Original Investigations. 36 (2018) 9 - p. 405-412 , 2018

Link: https://doi.org/10.1016/..

15

Characterization of metastatic urothelial carcinoma via com..:

Agarwal, Neeraj ; Pal, Sumanta K. ; Hahn, Andrew W....
Cancer. 124 (2018) 10 - p. 2115-2124 , 2018

Link: https://doi.org/10.1002/..